関: indometacin、indometacin farnesil、indometacin sodium、indomethacin、indomethacin sodium

WordNet

a nonsteroidal anti-inflammatory drug (trade name Indocin) (同)Indocin

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2015/12/01 10:43:20」(JST)

wiki en

Indometacin farnesil (INN) is a prodrug of the non-steroidal anti-inflammatory drug indometacin, designed to reduce the occurrence of side-effects by esterification of the carboxyl group on indometacin with farnesol. Indometacin farnesil was first approved in Japan in 1991, and is available in Japan and Indonesia, under the trade names Infree and Dialon respectively.

External links

Infree prescribing information from Eisai Co.

This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by expanding it.

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 発作性片側頭痛：臨床的特徴および診断 paroxysmal hemicrania clinical features and diagnosis
2. 発作性片側頭痛：治療および予後 paroxysmal hemicrania treatment and prognosis
3. 早産児における動脈管開存症のマネージメント management of patent ductus arteriosus in premature infants
4. 持続性片側頭痛 hemicrania continua
5. 一次性咳嗽性頭痛 primary cough headache

English Journal

Pseudogout of the acromioclavicular joint: report of two cases and review of the literature.

Hakozaki M1, Kikuchi S, Otani K, Tajino T, Konno S.
Modern rheumatology / the Japan Rheumatism Association.Mod Rheumatol.2011 Aug;21(4):440-3. doi: 10.1007/s10165-011-0417-8. Epub 2011 Feb 5.
Although calcium pyrophosphate dehydrate (CPPD) deposition disease, including pseudogout, is a relatively common disease affecting the major joints, especially the knee, pseudogout in the acromioclavicular (AC) joint is very uncommon. We describe two cases of acute pseudogout attacks of the AC joint
PMID 21298395

Keishikajutsubuto (Guizhi-shu-fu-tang) treatment for refractory accumulation of synovial fluid in a patient with pustulotic arthro-osteitis.

Satoh K1, Takano S, Kobayashi T.
Fukushima journal of medical science.Fukushima J Med Sci.2007 Jun;53(1):33-8.
We present a patient, a sixty-seven-year-old woman, who had refractory accumulation of synovial fluid in the knee joints with pustulotic arthro-osteitis for more than 10 years. Fifty ml of synovial fluid from her right knee contained 6,480 pg/ml of interleukin-8 (IL-8) and 15,000/mm3 of neutorophils
PMID 17957964

Successful treatment of primary Sjögren's syndrome with chronic natural killer lymphocytosis by high-dose prednisolone and indomethacin farnesil.

Fujita Y1, Fujii T, Takeda N, Tanaka M, Mimori T.
Internal medicine (Tokyo, Japan).Intern Med.2007;46(5):251-4. Epub 2007 Mar 1.
We report a patient with Sjögren's syndrome and chronic natural killer lymphocytosis, who developed severe neutropenia, autoimmune hemolytic anemia, and immune thrombocytopenia. High-dose prednisolone therapy improved the hemolytic anemia and thrombocytopenia, but not the CD16(+) CD56(-) NK lymphoc
PMID 17329922

Japanese Journal

Keishikajutsubuto (Guizhi-shu-fu-tang) treatment for refractory accumulation of synovial fluid in a patient with pustulotic arthro-osteitis

佐藤弘一郎,高野静子,小林利男
Fukushima journal of medical science 53(1), 33-38, 2007-06-01
… At first, she was treated with 400 mg/day of indomethacin farnesil (a prodrug that is converted to indomethacin after intestinal absorption) for 24 weeks. … Our data showed that Keishikajutsubuto might be suitable for this patient to regulate synovial fluid volume, reduce IL-8 concentration in synovial fluid, and block neutrophils migration to synovial fluid compared to indomethacin therapy. …
NAID 10026160146

KEISHIKAJUTSUBUTO (GUIZHI-SHU-FU-TANG) TREATMENT FOR REFRACTORY ACCUMULATION OF SYNOVIAL FLUID IN A PATIENT WITH PUSTULOTIC ARTHRO-OSTEITIS

SATOH KOICHIRO,TAKANO SHIZUKO,KOBAYASHI TOSHIO
FUKUSHIMA JOURNAL OF MEDICAL SCIENCE 53(1), 33-38, 2007
… At first, she was treated with 400 mg/day of indomethacin farnesil (a prodrug that is converted to indomethacin after intestinal absorption) for 24 weeks. … Our data showed that Keishikajutsubuto might be suitable for this patient to regulate synovial fluid volume, reduce IL-8 concentration in synovial fluid, and block neutrophils migration to synovial fluid compared to indomethacin therapy. …
NAID 130003387091

Successful Treatment of Primary Sjoegren's Syndrome with Chronic Natural Killer Lymphocytosis by High-Dose Prednisolone and Indomethacin Farnesil

Fujita Yoshimasa,Fujii Takao,Takeda Naho,Tanaka Masao,Mimori Tsuneyo
Internal Medicine 46(5), 251-254, 2007
… Interestingly, indomethacin farnesil (a prodrug of indomethacin) was effective for myalgia and also decreased the number of CD16+ CD56- NK cells. … NK lymphocytosis is rarely associated with autoimmune disease, but the combination of indomethacin and steroid therapy may have a favorable effect for such patients. …
NAID 130000078560

「indometacin farnesil」

Indometacin farnesil
Systematic (IUPAC) name
	(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl [1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]acetate
Clinical data
AHFS/Drugs.com	International Drug Names
Legal status	℞ (Prescription only);
Routes of; administration	Oral
Pharmacokinetic data
Metabolism	To indometacin
Biological half-life	1.5 hours
Excretion	Renal
Identifiers
CAS Number	85801-02-1
ATC code	None
PubChem	CID: 5282183
ChemSpider	4445378
Chemical data
Formula	C34H40ClNO4
Molecular mass	562.14 g/mol
	SMILES CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)OCC=C(C)CCC=C(C)CCC=C(C)C ;
	InChI InChI=1S/C34H40ClNO4/c1-23(2)9-7-10-24(3)11-8-12-25(4)19-20-40-33(37)22-30-26(5)36(32-18-17-29(39-6)21-31(30)32)34(38)27-13-15-28(35)16-14-27/h9,11,13-19,21H,7-8,10,12,20,22H2,1-6H3/b24-11+,25-19+ ; Key:CFIGYZZVJNJVDQ-LMJOQDENSA-N ;
(what is this?) (verify)